glp 1 analog drugs GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 Genetics: How Genes Affect

2,3 Obesity is a complex, multifactorial condition influenced by various interrelated factors, including lifestyle, medications, genetics, medical conditions, gut hormones and psychological aspects

Glucagon-like peptide-1 receptor agonists may offer a novel therapeutic strategy that addresses both metabolic and neuropsychiatric dimensions of addiction, warranting further investigation to define their role in the evolving landscape of substance use disorder treatment

[DOI] [PMC free article] [PubMed] [Google Scholar] 112.Moll H., Frey E., Gerber P., et al

Combining these drugs with GLP-1RAs can enhance the relief of pain through targeting multiple mechanisms, including reducing inflammation, oxidative stress, and central sensitization